Rare diseases
Investigational molecules
Locations
Back to France3 344 clinical trials in Saint-Cloud, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study of BI 764198 for Patients with Focal Segmental Glomerulosclerosis
FranceStudy on Selumetinib for Adults with Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas
FranceStudy of Alectinib and Platinum-Based Chemotherapy for Patients with Resected Stage Ib to IIIa ALK-Positive Non-Small Cell Lung Cancer
FranceStudy of MK-4280A (Favezelimab and Pembrolizumab) for Patients with Metastatic Colorectal Cancer After Previous Treatment
FranceStudy of Tisagenlecleucel for Adults with Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma
FranceStudy on GR1014 Gel to Prevent Skin Damage from Radiation in Breast Cancer Patients After Lumpectomy
FranceStudy on the Effectiveness and Safety of Subcutaneous Infliximab for Patients with Active Crohn's Disease or Ulcerative Colitis
FranceA Study of GEN1047 in Patients with Solid Tumors: First Time Use in Humans
FranceStudy of Long-term Safety of Tazemetostat in Patients Who Previously Participated in Tazemetostat Clinical Trials
FranceStudy on the Safety and Effects of YTB323, Fludarabine Phosphate, and Tocilizumab in Patients with Severe, Refractory Systemic Lupus Erythematosus
FranceStudy on the Effects of INT-787 for Patients with Severe Alcohol-Associated Hepatitis
FranceStudy on Glenzocimab for Patients with Large Ischemic Stroke Eligible for Endovascular Therapy
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on lymphoma and multiple myeloma treatments, including studies of novel therapies like duvelisib for T-cell lymphoma and odronextamab for follicular lymphoma.
Several studies are evaluating combination therapies and comparing new treatment approaches against standard care.
Comprehensive research into various types of breast cancer, with particular focus on hormone receptor-positive and triple-negative variants. Studies include early detection methods and novel therapeutic combinations.
Trials incorporate innovative approaches like ctDNA monitoring and targeted therapies.
Research focusing on targeted therapies for various advanced cancers, including studies of biliary tract cancer and non-small cell lung cancer treatments.
Emphasis on immunotherapy combinations and precision medicine approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
